Profile

Michael V. Rocco, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

76 Ratings
2 Comments
 

Michael V. Rocco, M.D.

Professor,

Clinical Interests

Renal Failure, Nephrolithiasis, Kidney Disease, Hemodialysis, Acute Kidney Injury, Clinical Nephrology, Dialysis, Hypertension

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-2097
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • B.S., Seton Hall University, 1981
  • M.D., Vanderbilt University School of Medicine, 1985
  • M.S., WFU School of Medicine, 1994
  • Residency, Vanderbilt U Affil Hosps, 1988
  • Fellowship, Hosp Of The Univ Penn, 1991

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Nat'L Kidney Foundation
  • Am Soc Of Nephrology

NPI Number

  • 1437134525
Michael V. Rocco, M.D.

Doctor Rating

4.6 out of 5

76 Ratings
2 Comments
 

Michael V. Rocco, M.D.

Professor, Nephrology
Public Health Sciences

Research Interests

Renal Dialysis; Kidney Failure, Chronic; Kidney Diseases; Hemodialysis, Home; Nutritional Status
More »

Contact Information

Academic: 336-716-2097 | Department: 336-716-4650

Recent Publications

Long-term effects of frequent in-center hemodialysis. Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T.. J Am Soc Nephrol. 2016;27(6):1830-1836.

A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists. Rocco MV, Cheung AK.. Kidney Int. 2016;89(2):261-263.

Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation. Dixon BS, VanBuren JM, Rodrigue JR, Lockridge RS, Lindsay R, Chan C, Rocco MV, Oleson JJ, Beglinger L, Duff K, Paulsen JS.. BMC Nephrol. 2016;17(1):12.

Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Mehta RL, Burdmann EA, Cerda J, Feehally J, Finkelstein F, Garcia-Garcia G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G.. Lancet. 2016;387(10032):2017-2025.

APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease. Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, Divers J, Palmer ND, Hicks PJ, Bowden DW, Lea JP, Krisher JO, Clay MJ, Freedman BI.. Kidney Int. 2016;90(2):389-395.

Beta-blocker use is associated with higher renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, Hall JE, Hundley WG.. Cardiorenal Med. 2016;6(4):261-268.

The effect of increased frequency of hemodialysis on volume-related outcomes: a secondary analysis of the frequent hemodialysis network trials. Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW, Burkart J, Moossavi S, et al.. Blood Purif. 2016;41(4):277-286.

APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT Jr, Bowden DW, Williamson JD, Sink KM,.. Kidney Int. 2016;90(2):440-449.

Ultrafiltration rate thresholds in maintenance hemodialysis: an NKF-KDOQI controversies report. Kramer H, Yee J, Weiner DE, Bansal V, Choi MJ, Brereton L, Berns JS, Samaniego-Picota M, Scheel P Jr, Rocco M.. Am J Kidney Dis. 2016;():.

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI.. Kidney Int. 2015;87(1):169-175.

A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines. Haller MC, van der Veer SN, Nagler EV, Tomson C, Lewington A, Hemmelgarn BR, Gallagher M, Rocco M, Obrador G, Vanholder R, Craig JC, Van Biesen W.. Nephrol Dial Transplant. 2015;30(7):1066-1074.

International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Mehta RL, Cerda J, Burdmann EA, Tonelli M, Garcia-Garcia G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G.. Lancet. 2015;385(9987):2616-2643.

Long-term effects of frequent nocturnal hemodialysis on mortality: the Frequent Hemodialysis Network (FHN) Nocturnal Trial. Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS.. Am J Kidney Dis. 2015;66(3):459-468.

High intensity crossfit exercise increases beta-cell function and insulin sensitivity in adults with type 2 diabetes [abstract]. Fealy CE, Nieuwoudt S, Scelsi AR, Malin SK, Foucher JA, Pagadala M, Li M, Rocco M, Burguera B, Kirwan JP.. Diabetes. 2015;64(Suppl 1):A204-A205.

High intensity crossfit exercise attenuates cardiometabolic risk factors in adults with type 2 diabetes [abstract]. Nieuwoudt S, Fealy CE, Scelsi AR, Malin SK, Foucher JA, Navaneethan SD, Li M, Rocco M, Burguera B, Kirwan JP.. Diabetes. 2015;64(Suppl 1):A205.

A randomized trial of intensive versus standard blood-pressure control. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT, Kitzman DW, et al.. N Engl J Med. 2015;373(22):2103-2116.

KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, Weiner DE.. Am J Kidney Dis. 2015;66(5):884-930.

ISN 0by25 AKI Global Snapshot Project: AKI disposition [abstract]. Rocco MV, Mehta RL, Remuzzi G, Zhang J, Godin M, Burdmann EA, Feehally J, Finkelstein FO, Garcia G, Lombardi R, Macedo E.. J Am Soc Nephrol. 2015;26(Abstract Suppl):461A.

ISN 0by25 AKI Global Snapshot Project: indications for initiating and withholding dialysis in AKI worldwide [abstract]. Macedo E, Mehta RL, Remuzzi G, Zhang J, Godin M, Rocco MV.. J Am Soc Nephrol. 2015;26(Abstract Suppl):461A.

ISN 0by25 AKI Global Snapshot Project: differences in location and process of care among AKI patients around the globe [abstract]. Macedo E, Mehta RL, Remuzzi G, Zhang J, Godin M, Rocco MV.. J Am Soc Nephrol. 2015;26(Abstract Suppl):462A.

ISN 0by25 AKI Global Snapshot Project: risk factors for AKI [abstract]. Mehta RL, Remuzzi G, Zhang J, Godin M, Rocco MV, Cerda J, Feehally J, Finkelstein FO, Levin NW, Tonelli M.. J Am Soc Nephrol. 2015;26(Abstract Suppl):462A.

ISN 0by25 AKI Global Snapshot Project: KDIGO classification and AKI diagnosis around the globe [abstract]. Macedo E, Mehta RL, Remuzzi G, Zhang J, Godin M, Rocco MV.. J Am Soc Nephrol. 2015;26(Abstract Suppl):462A.

ISN 0by25 AKI Global Snapshot Project: evaluation and treatment [abstract]. Cerda J, Mehta RL, Remuzzi G, Zhang J, Godin M, Rocco MV, Burdmann EA, Garcia G, Jha V, Lewington AJP, Lombardi R.. J Am Soc Nephrol. 2015;26(Abstract Suppl):463A.

ISN 0by25 AKI Global Snapshot Project: provider characteristics [abstract]. Godin M, Mehta RL, Remuzzi G, Zhang J, Rocco MV, Cerda J, Jha V, Levin NW, Lewington AJP, Macedo E, Tonelli M.. J Am Soc Nephrol. 2015;26(Abstract Suppl):463A.

Beta blockers improve renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis [abstract]. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, Hall JE, Hundley WG.. Circulation. 2015;132(Suppl 3):A9839.

Chronic hemodialysis therapy in the West. Rocco MV.. Kidney Dis (Basel). 2015;1(3):178-186.

Gene-gene interactions in APOL1-associated nephropathy. Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI.. Nephrol Dial Transplant. 2014;29(3):587-594.

Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Edwards MS, Jordan JH, Hurie JB, Hundley WG.. J Cardiovasc Magn Reson. 2014;16(1):17.

The role of perioperative sodium bicarbonate infusion affecting renal function after cardiothoracic surgery. Turner KR, Fisher EC, Hade EM, Houle TT, Rocco MV.. Front Pharmacol. 2014;5():127.

New dialysis techniques [abstract]. Rocco M, Daugirdas J, Greene T, Lockridge R, Chan C, Pierratos A, Lindsay R, Larive B, Chertow G, Beck G, Eggers P, Kliger A, Laville M, Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL, Juillard L, Debska-Slizien A, Fernandez Lorente L, Thibaudin D,.. Nephrol Dial Transplant. 2014;29(Suppl 3):.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Williamson JD, Wright JT Jr, Whelton PK.. Clin Trials. 2014;11(5):532-546.

Long-term effects of frequent in-center hemodialysis: FHN daily trial [abstract]. Kliger AS, Chertow GM, Levin NW, Beck CJ, Daugirdas JT, Eggers PW, Larive B, Rocco MV, Greene T.. Nephrol Dial Transplant. 2014;29(Suppl 3):37-38.

25-hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report. Kramer H, Berns JS, Choi MJ, Martin K, Rocco MV.. Am J Kidney Dis. 2014;64(4):499-509.

Mortality during extended follow-up in the frequent hemodialysis network nocturnal trial [abstract]. Rocco M, Daugirdas J, Greene T, Lockridge R, Chan C, Pierratos A, Lindsay R, Larive B, Chertow G, Beck G, Eggers P, Kliger A.. Nephrol Dial Transplant. 2014;29(Suppl 3):37.

Low predialysis serum sodium modifi es the effect of hemodialysis (HD) frequency on left ventricular mass: the frequent hemodialysis network (FHN) trial [abstract]. Raimann JG, Chan CT, Daugirdas JT, Depner TA, Gotch FA, Green T, Kaysen GA, Kliger AS, Kotanko P, Lindsay RM, Rocco MV, Chertow GM, Levin NW.. J Am Soc Nephrol. 2014;25(Abstract Suppl):20A.

The role of cardiomyocyte apoptosis in the pathogenesis of left ventricular hypertrophy (LVH): results from the frequent hemodialysis network (FHN) [abstract]. Chan CT, Rocco MV, Chertow GM, Kaysen GA, Levin NW, Larive B, Beck GJ, Kliger AS.. J Am Soc Nephrol. 2014;25(Abstract Suppl):34A-34B.

Association between apolipoprotein L1 gene variants with prevalent kidney and cardiovascular disease: systolic blood pressure intervention trial (SPRINT) [abstract]. Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin D, Bild D, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT, Sedor JR, Rocco MV, Freedman BI.. J Am Soc Nephrol. 2014;25(Abstract Suppl):415A.

Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes. Chan CT, Covic A, Craig JC, Davenport A, Kasiske BL, Kuhlmann MK, Levin NW, Li PK, Locatelli F, Rocco MV, Wheeler DC.. Kidney Int. 2013;83(3):359-371.

Risk of vascular access complications with frequent hemodialysis. Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS.. J Am Soc Nephrol. 2013;24(3):498-505.

Does more frequent hemodialysis provide dietary freedom?. Rocco MV.. J Ren Nutr. 2013;23(3):259-262.

Effect of frequent hemodialysis on residual kidney function. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS.. Kidney Int. 2013;83(5):949-958.

Ethnicity, medical insurance, and living kidney donation. Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI.. Clin Transplant. 2013;27(4):E498-E503.

Gene-gene interactions in APOL1-associated nephropathy [abstract]. Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI.. J Am Soc Nephrol. 2013;24(Abstract Suppl):67A.

Bayesian interpretation of the estimated treatment effects on mortality in the daily and nocturnal Frequent Hemodialysis Trials (FHN) [abstract]. Greene T, Daugirdas JT, Chertow GM, Levin NW, Rocco MV, Beck GJ, Kliger AS.. J Am Soc Nephrol. 2013;24(Abstract Suppl):439A.

The magnitude of phosphorus mobilization during dialysis in the Frequent Hemodialysis Network (FHN) daily trial was patient-specific [abstract]. Daugirdas JT, Larive B, Depner TA, Pierratos A, Greene T, Lockridge RS, Ayus JC, Rocco MV, Chertow GM, Leypoldt JK, Akonur A, Miller BW.. J Am Soc Nephrol. 2013;24(Abstract Suppl):439A.

Effects of randomization to frequent in-center hemodialysis on long-term mortality: Frequent Hemodialysis Daily Trial [abstract]. Chertow GM, Levin NW, Back GJ, Eggers PW, Greene T, Larive B, Rocco MV, Kliger AS.. J Am Soc Nephrol. 2013;24(Abstract Suppl):442A.

Influence of methodology on left ventricular mass measurement by cardiac magnetic resonance in the Frequent Hemodialysis Network (FHN) Nocturnal Trial [abstract]. Beck GJ, Chertow GM, Eggers PW, Greene T, Larive B, Levin NW, Rajagopalan S, Rocco MV, Sanz J, Tran T, Kramer C, Kliger AS.. J Am Soc Nephrol. 2013;24(Abstract Suppl):726A.

Effects of randomization to frequent nocturnal hemodialysis on long-term mortality: Frequent Hemodialysis Network Nocturnal Trial [abstract]. Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Pierratos A, Larive B, Beck GJ, Kliger AS.. J Am Soc Nephrol. 2013;24(Abstract Suppl):443A.

Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers. Estrella MM, Jaar BG, Cavanaugh KL, Fox CH, Perazella MA, Soman SS, Howell E, Rocco MV, Choi MJ.. BMC Nephrol. 2013;14(1):230.

JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Divers J, Nunez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI.. Kidney Int. 2013;84(6):1207-1213.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Renal Failure, Nephrolithiasis, Kidney Disease, Hemodialysis, Acute Kidney Injury, Clinical Nephrology, Dialysis, Hypertension
Michael V. Rocco, M.D.

Michael V. Rocco, M.D.

Professor, Nephrology
Public Health Sciences

Doctor Rating

4.6 out of 5

Michael V. Rocco, M.D.76 Ratings
2 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.6
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.7
Time CP spent with patient
4.6
Wait time at clinic
4.0



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/8/2016

Since '98-'99, ALWAYS superior.

3/4/2016

Everyone I came in contact was very professional & helpful.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.